Skip to main content

Market Overview

8 Mergers You Might Have Missed On Tuesday

8 Mergers You Might Have Missed On Tuesday
  • Jazz Pharmaceuticals (NASDAQ: JAZZ) announced it's acquiring Celator Pharmaceuticals (NASDAQ: CPXX) for $1.5 billion. Celator's Vyxeos, a drug that battles leukemia, is a great expansion of Jazz's drug portfolio and international reach.
  • Great Plains Energy (NYSE: GXP) is buying rival Westar Energy (NYSE: WR) for $8.6 billion. The combination of the two companies creates the largest power provider in the Kansas and Missouri region with more than 1.5 million customers.
  • ContraVir (NASDAQ: CTRV) agreed to a merger with Ciclofilin for aggregate cash of $17 million and 10 percent of ContraVir's issues and outstanding common stocks. CTRV will expand its Hepatitis B portfolio with Ciclofilin's CPI-431-32.
  • Rose Rock Midstream (NYSE: RRMS) has entered into an agreement with SemGroup Corporation (NYSE: SEMG). SemGroup will buy all of the outstanding common units of RRMS in a stock for unit transaction.
  • SANW S&W Seed Company has announced the acquisition of SV Genetics a company based in Qeensland, Australia for 1$ million in cash and $1 million in S&W common stock to be paid at closing.
  • SciQuest Inc. (NASDAQ: SQI) has entered into an agreement with Accel-KKR to be taken private for a deal valued at $509 million.
  • Electro Rent Corporation (NASDAQ: ELRC) and Platinum Equity announced a deal valued at $323.4 million. Platinum Equity is a private equity firm with over $6 billion in assets under management.

Related Articles (JAZZ + CPXX)

View Comments and Join the Discussion!

Posted-In: M&A News Intraday Update Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at